LLY Eli Lilly and Company
Stock · NYSE · United States · Healthcare · US5324571083
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Eli Lilly and Company, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price
1,427.28 USD
-0.70%
52-week range
850.51 – 1,460.00
Dividend yield0.48%
Market cap1.3T
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 05:41. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
03 Feb 2027
in 82 days · 08:00 · estimate 11.23
Last results
7.48 vs 6.35 estimated
29 Oct 2026 · Beat +17.9%
Beat the estimate
10 of 12
2 missed · 0 in line · 6 beats in a row
Average surprise
+12.1%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 03 Feb 2027 08:00 | 11.23 | — | — | Upcoming |
| 29 Oct 2026 06:00 | 6.35 | 7.48 | +17.9% | Beat |
| 05 Aug 2026 06:00 | 6.58 | 8.38 | +27.3% | Beat |
| 30 Apr 2026 06:00 | 6.79 | 8.55 | +25.9% | Beat |
| 04 Feb 2026 06:00 | 6.91 | 7.54 | +9.1% | Beat |
| 30 Oct 2025 06:00 | 5.89 | 7.02 | +19.2% | Beat |
| 07 Aug 2025 06:00 | 5.59 | 6.31 | +12.9% | Beat |
| 01 May 2025 06:00 | 3.46 | 3.34 | -3.4% | Miss |
| 06 Feb 2025 06:00 | 5.07 | 5.32 | +5.0% | Beat |
| 30 Oct 2024 06:00 | 1.47 | 1.18 | -19.5% | Miss |
| 08 Aug 2024 07:00 | 2.77 | 3.92 | +41.7% | Beat |
| 30 Apr 2024 06:00 | 2.49 | 2.58 | +3.7% | Beat |
| 06 Feb 2024 06:00 | 2.37 | 2.49 | +5.1% | Beat |
| 02 Nov 2023 06:00 | -0.12 | 0.10 | +181.5% | Beat |
| 08 Aug 2023 06:00 | 1.99 | 2.11 | +5.9% | Beat |
| 27 Apr 2023 06:00 | 1.73 | 1.62 | -6.3% | Miss |
| 02 Feb 2023 06:00 | 1.83 | 2.09 | +14.1% | Beat |
| 01 Nov 2022 06:00 | 1.94 | 1.98 | +2.1% | Beat |
| 04 Aug 2022 06:00 | 1.70 | 1.25 | -26.3% | Miss |
| 28 Apr 2022 06:00 | 2.29 | 2.62 | +14.4% | Beat |
| 03 Feb 2022 06:00 | 2.51 | 2.49 | -0.7% | In line |
| 26 Oct 2021 06:00 | 1.96 | 1.94 | -1.3% | Miss |
| 03 Aug 2021 06:00 | 1.89 | 1.87 | -1.0% | Miss |
| 27 Apr 2021 06:00 | 2.10 | 1.87 | -10.9% | Miss |
| 29 Jan 2021 06:00 | 2.39 | 2.75 | +15.1% | Beat |
| 27 Oct 2020 06:00 | 1.71 | 1.54 | -10.0% | Miss |
| 30 Jul 2020 06:00 | 1.60 | 1.89 | +18.1% | Beat |
| 23 Apr 2020 06:00 | 1.48 | 1.75 | +17.9% | Beat |
| 30 Jan 2020 06:00 | 1.52 | 1.73 | +13.9% | Beat |
| 23 Oct 2019 06:00 | 1.41 | 1.48 | +4.8% | Beat |
| 30 Jul 2019 06:00 | 1.45 | 1.50 | +3.7% | Beat |
| 30 Apr 2019 06:00 | 1.33 | 1.33 | -0.1% | In line |
| 06 Feb 2019 06:00 | 1.33 | 1.33 | -0.3% | In line |
| 06 Nov 2018 06:00 | 1.35 | 1.39 | +3.3% | Beat |
| 24 Jul 2018 06:00 | 1.30 | 1.50 | +15.8% | Beat |
| 24 Apr 2018 06:00 | 1.13 | 1.34 | +18.3% | Beat |
| 31 Jan 2018 06:00 | 1.07 | 1.14 | +6.2% | Beat |
| 24 Oct 2017 06:00 | 1.03 | 1.05 | +2.0% | Beat |
| 25 Jul 2017 06:00 | 1.05 | 1.11 | +5.4% | Beat |
| 25 Apr 2017 06:00 | 0.96 | 0.98 | +1.8% | Beat |
| 31 Jan 2017 06:00 | 0.98 | 0.95 | -3.4% | Miss |
| 25 Oct 2016 06:00 | 0.96 | 0.88 | -8.3% | Miss |
| 26 Jul 2016 06:00 | 0.86 | 0.86 | +0.4% | In line |
| 26 Apr 2016 06:00 | 0.85 | 0.83 | -2.0% | Miss |
| 28 Jan 2016 06:00 | 0.78 | 0.78 | -0.5% | In line |
| 22 Oct 2015 06:00 | 0.76 | 0.89 | +16.7% | Beat |
| 23 Jul 2015 06:00 | 0.74 | 0.90 | +22.1% | Beat |
| 23 Apr 2015 06:00 | 0.74 | 0.87 | +17.4% | Beat |
| 30 Jan 2015 06:00 | 0.73 | 0.75 | +2.5% | Beat |
| 23 Oct 2014 06:00 | 0.67 | 0.66 | -1.2% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 65.2B | +44.7% | 20.6B | 31.7% | 22.95 | +96.0% | 6B |
| 2024 | 45B | +32.0% | 10.6B | 23.5% | 11.71 | +101.9% | 414M |
| 2023 | 34.1B | +19.6% | 5.2B | 15.4% | 5.80 | -11.7% | -3.2B |
| 2022 | 28.5B | — | 6.2B | 21.9% | 6.57 | — | 4.6B |
| 2021 | — | — | — | — | — | — | — |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 1,393.15 | 1,460.00 | 1,333.22 | 1,427.28 | +0.69% | 30,218,600 | |
| Oct 2026 | 1,155.00 | 1,449.68 | 1,131.21 | 1,417.54 | +22.51% | 54,900,800 | |
| Sep 2026 | 1,188.00 | 1,215.00 | 1,113.29 | 1,157.08 | +0.03% | 48,403,800 | |
| Aug 2026 | 1,152.00 | 1,292.65 | 1,109.15 | 1,156.73 | +0.69% | 60,086,300 | 1.7300 |
| Jul 2026 | 1,217.51 | 1,249.45 | 1,119.00 | 1,148.84 | -4.22% | 53,059,000 | |
| Jun 2026 | 1,095.00 | 1,238.00 | 1,052.15 | 1,199.43 | +8.55% | 71,573,200 | |
| May 2026 | 948.95 | 1,149.10 | 943.26 | 1,105.00 | +18.23% | 66,346,000 | 1.7300 |
| Apr 2026 | 926.88 | 976.68 | 850.51 | 934.60 | +1.61% | 67,156,600 | |
| Mar 2026 | 1,044.62 | 1,056.20 | 877.11 | 919.77 | -12.57% | 62,116,100 | |
| Feb 2026 | 1,037.57 | 1,114.00 | 993.58 | 1,051.99 | +1.43% | 72,505,500 | 1.7300 |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Jefferies Raised Its Eli Lilly (LLY) Target to $1,700. Here’s What the Firm Is Counting On (opens in a new tab) Insider Monkey · 12 Nov 2026 22:34
- Eli Lilly secures first approval for weight-loss pill in China (opens in a new tab) Proactive · 12 Nov 2026 16:15
- What Does Eli Lilly (LLY) Foundayo Sleep Apnea Success Mean For Its Obesity Franchise? (opens in a new tab) Simply Wall St. · 12 Nov 2026 16:11
- Baron Funds Sees Eli Lilly’s (LLY) Mounjaro, Zepbound and Orforglipron as Transformational (opens in a new tab) Insider Monkey · 12 Nov 2026 11:32
- Can LLY's Expanding Obesity Pipeline Sustain Its GLP-1 Leadership? (opens in a new tab) Zacks · 12 Nov 2026 11:30
- Eli Lilly Shares Rise 2.8% After China Approves Orforglipron Weight-Loss Pill (opens in a new tab) InvestorsHub · 12 Nov 2026 11:24
- State Street Health Care SPDR (XLV) Adds Eli Lilly and Johnson & Johnson on Nov. 10 (opens in a new tab) GuruFocus.com · 12 Nov 2026 11:05
- Is Eli Lilly (LLY) Priced Below Its Cash Flow Potential? (opens in a new tab) 12 Nov 2026 01:18
- S&P 500 After-Hours Movers: MNST, RDDT Among Gainers; VEEV, LLY Among Losers in Latest Session (opens in a new tab) ChartMill · 11 Nov 2026 22:06
- State Street Health Care SPDR (XLV) Sells Eli Lilly and J&J on Nov. 9 (opens in a new tab) 11 Nov 2026 11:04
- Eli Lilly and Company (LLY) Grew Revenue 48% as GLP-1 Demand Accelerated: Can Growth Continue? (opens in a new tab) Insider Monkey · 10 Nov 2026 15:59
- The FDA Ordered GLP-1 Vision-Loss Warnings For Some Products. Shares of Eli Lilly and Novo Nordisk Were Unfazed. (opens in a new tab) International Business Times · 10 Nov 2026 12:41
- Zacks Industry Outlook Highlights Eli Lilly, Novartis and Bayer (opens in a new tab) Zacks · 10 Nov 2026 05:50
- Eli Lilly Stocks Rise 3.40% as Jefferies Sets Street-High $1,700 Target (opens in a new tab) GuruFocus.com · 09 Nov 2026 18:17
- FDA requires vision-loss warning on Novo Nordisk and Eli Lilly GLP-1 drugs (opens in a new tab) Investing.com · 09 Nov 2026 17:06
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 1,437.29 USD
- Market cap
- 1.3T
- Dividend yield
- 0.48%
- 5-year average yield
- 0.75%
- Payout ratio
- 22%
- Last dividend
- 1.7300 USD · 13 Nov 2026
- Next ex-dividend date
- 13 Nov 2026
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 14 Aug 2026 | 1.7300 USD |
| 15 May 2026 | 1.7300 USD |
| 13 Feb 2026 | 1.7300 USD |
| 14 Nov 2025 | 1.5000 USD |
| 8 older dividends: create a free account to see them | |
Why this score
Similar shares
Follow LLY and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.